Literature DB >> 15642762

Tissue factor cytoplasmic domain stimulates migration by activation of the GTPase Rac1 and the mitogen-activated protein kinase p38.

Ilka Ott1, Berthold Weigand, Ruth Michl, Isabell Seitz, Nooshin Sabbari-Erfani, Franz-Josef Neumann, Albert Schömig.   

Abstract

BACKGROUND: Tissue factor (TF), the surface receptor for the serine protease factor VIIa (FVIIa) and the initiator of the extrinsic coagulation cascade, supports vessel development and tumor metastasis by activation of extracellular, protease-dependent signaling pathways. The molecular mechanisms that do not require proteolytic activity of FVIIa are not yet known. The aim of the study, therefore, was to investigate the effects of active-site-inhibited FVIIa (FFR-FVIIa) on TF-mediated signaling. METHODS AND
RESULTS: After stimulation with FVIIa and FFR-FVIIa, migration and activation of the GTPase Rac (Rac1) or the mitogen-activated protein kinase p38 (p38) were analyzed in J82 cells. FVIIa and FFR-FVIIa stimulated migration and activation of Rac1 and p38 in a TF-specific, dose- and time-dependent manner. Enhancement of migration required activation of Rac1 and p38, because it was abolished after inhibition with SB203580 or overexpression of dominant negative p38 and Rac1. The cytoplasmic domain of TF was necessary because no effects of FFR-FVIIa could be detected after transfection of a TF deletion mutant lacking the cytoplasmic domain.
CONCLUSIONS: We identified a novel signaling pathway through which TF stimulates migration by activation of p38 and Rac1 independent of the proteolytic activity of FVIIa but dependent on the cytoplasmic domain of TF. Binding of FFR-VIIa to TF may stimulate vessel wall remodeling by enhancement of migration through activation of Rac1 and p38. This novel link may provide an insight into the understanding of the nonhemostatic functions of TF.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15642762     DOI: 10.1161/01.CIR.0000153333.52294.42

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  24 in total

Review 1.  Protease-activated receptor signalling by coagulation proteases in endothelial cells.

Authors:  Alireza R Rezaie
Journal:  Thromb Haemost       Date:  2014-07-03       Impact factor: 5.249

Review 2.  Tissue factor pathways linking obesity and inflammation.

Authors:  W Ruf; F Samad
Journal:  Hamostaseologie       Date:  2015-01-27       Impact factor: 1.778

3.  Tumor cell-associated tissue factor and circulating hemostatic factors cooperate to increase metastatic potential through natural killer cell-dependent and-independent mechanisms.

Authors:  Joseph S Palumbo; Kathryn E Talmage; Jessica V Massari; Christine M La Jeunesse; Matthew J Flick; Keith W Kombrinck; Zhiwei Hu; Kelley A Barney; Jay L Degen
Journal:  Blood       Date:  2007-03-19       Impact factor: 22.113

Review 4.  Tissue factor: newer concepts in thrombosis and its role beyond thrombosis and hemostasis.

Authors:  Giovanni Cimmino; Plinio Cirillo
Journal:  Cardiovasc Diagn Ther       Date:  2018-10

5.  Tissue factor trafficking in fibroblasts: involvement of protease-activated receptor-mediated cell signaling.

Authors:  Samir K Mandal; Usha R Pendurthi; L Vijaya Mohan Rao
Journal:  Blood       Date:  2007-03-23       Impact factor: 22.113

Review 6.  Inflammation, obesity, and thrombosis.

Authors:  Fahumiya Samad; Wolfram Ruf
Journal:  Blood       Date:  2013-10-03       Impact factor: 22.113

7.  Tissue factor mediates the HGF/Met-induced anti-apoptotic pathway in DAOY medulloblastoma cells.

Authors:  Mathieu Provençal; Nancy Berger-Thibault; David Labbé; Ryan Veitch; Dominique Boivin; Georges-Etienne Rivard; Denis Gingras; Richard Béliveau
Journal:  J Neurooncol       Date:  2009-11-18       Impact factor: 4.130

Review 8.  Targeting clotting proteins in cancer therapy - progress and challenges.

Authors:  Wolfram Ruf; Andrea S Rothmeier; Claudine Graf
Journal:  Thromb Res       Date:  2016-04       Impact factor: 3.944

9.  Biological relevance of tissue factor and IL-6 in arteriovenous malformations.

Authors:  Shouhei Noshiro; Takeshi Mikami; Yuko Kataoka-Sasaki; Masanori Sasaki; Kazuo Hashi; Shunya Ohtaki; Masahiko Wanibuchi; Nobuhiro Mikuni; Jeffery D Kocsis; Osamu Honmou
Journal:  Neurosurg Rev       Date:  2016-08-19       Impact factor: 3.042

10.  Inhibition of tissue factor signaling suppresses tumor growth.

Authors:  Henri H Versteeg; Florence Schaffner; Marjolein Kerver; Helle H Petersen; Jasimuddin Ahamed; Brunhilde Felding-Habermann; Yoshikazu Takada; Barbara M Mueller; Wolfram Ruf
Journal:  Blood       Date:  2007-09-27       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.